An untreated blood clot can do anything from dissolving quietly on its own to killing you within hours, and the outcome depends almost entirely on where the clot forms, how large it is, and whether it stays put or travels. A small clot in a calf vein often breaks down without anyone ever knowing it was there. A clot that grows into the upper leg veins and breaks loose can lodge in the lungs and become life-threatening. An arterial clot blocking blood flow to the brain or heart can cause permanent damage in minutes. The range of possibilities is wide, but the serious end of that range is serious enough that understanding the different scenarios matters.
Where a Clot Forms Changes Everything
Blood clots are not all the same. Clots that form in veins, especially the deep veins of the legs and pelvis, are called deep vein thromboses. These are composed mostly of red blood cells trapped in a mesh of fibrin, and they form under conditions of slow blood flow, blood that clots too easily, or damaged vessel walls. Clots that form in arteries are a different animal: they tend to be rich in platelets and develop at sites where fatty plaques have ruptured in the vessel lining, which is the mechanism behind most heart attacks and strokes.1Scientific Reports. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli A third category, microvascular clotting, involves tiny clots forming throughout the smallest blood vessels in the body, usually in the setting of severe infection. Each type follows a different trajectory when left untreated.
When a Leg Clot Travels to the Lungs
The most feared immediate consequence of an untreated deep vein thrombosis is pulmonary embolism, where a piece of the clot breaks free, travels through the bloodstream, and lodges in the arteries of the lungs. Pulmonary embolism can range from small and barely noticeable to massive and immediately fatal.2PubMed. Epidemiology, Pathophysiology, Stratification, and Natural History of Pulmonary Embolism When a large embolus blocks enough of the pulmonary circulation, the right side of the heart has to pump against dramatically increased resistance. The right ventricle dilates and becomes unable to contract effectively, which can lead to cardiovascular collapse.3Chest. Echocardiographic Evaluation of Pulmonary Embolism and Its Response to Therapeutic Interventions
How often does this happen? Patients with clots in the upper leg veins who go inadequately treated have roughly a 47% chance of experiencing a recurrent clot or pulmonary embolism within three months.4PubMed Central. Pathophysiology and diagnosis of deep venous thrombosis That is nearly a coin flip, and it underscores why proximal DVT is treated aggressively with blood thinners. The traditional estimate for mortality from untreated or missed pulmonary embolism has been around 26% to 30%, though a closer look at ambulatory patients (those who were walking around and otherwise functional at the time of diagnosis) suggests the actual death rate in that group is under 5%.5PubMed. The mortality of untreated pulmonary embolism in emergency department patients The discrepancy reflects the fact that smaller emboli in otherwise healthy people carry much less risk than large emboli in patients who are already sick or immobilized.
The Damage That Stays Behind After DVT
Even when a deep vein thrombosis does not travel to the lungs, leaving it untreated sets the stage for long-term problems in the affected leg. Post-thrombotic syndrome develops in roughly 20% to 50% of people after a DVT, and severe cases, including open skin ulcers on the leg, affect about 5% to 10%.6PubMed Central. The post-thrombotic syndrome The syndrome occurs because the clot damages the valves inside the vein. Normally, those valves keep blood flowing upward toward the heart. Once they are destroyed by inflammation from the clot, blood pools in the lower leg, leading to chronic swelling, aching, skin discoloration, and in the worst cases, ulcers that are difficult to heal.
One study that followed patients with proximal DVT for an average of just over two years found that more than a third had developed post-thrombotic syndrome, with 4% experiencing the severe form.7PubMed. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis Quality of life was measurably worse in these patients. The frustrating part is that this damage is largely irreversible once it develops. The vein valves do not regenerate. So while the clot itself may eventually be absorbed by the body, the wreckage it leaves in the vein lining keeps causing problems for years.
Chronic Pulmonary Hypertension After an Embolism
A parallel long-term problem exists in the lungs. When a pulmonary embolism does not fully dissolve, the leftover clot material can organize into scar-like tissue that permanently narrows the pulmonary arteries. Over time, the increased pressure in those arteries leads to chronic thromboembolic pulmonary hypertension, or CTEPH. This condition is estimated to develop in about 1% to 4% of patients after an acute pulmonary embolism. If it goes unrecognized and untreated, it leads to progressive right heart failure and frequently death.8PubMed Central. Pulmonary hypertension after pulmonary emboli: an underrecognized condition
CTEPH is worth knowing about because it is both underdiagnosed and potentially curable with surgery. Patients who survive a pulmonary embolism and continue to feel short of breath months later sometimes chalk it up to deconditioning or anxiety, when the real problem is that organized clot material is still obstructing their pulmonary arteries. A specialized operation can remove that material and restore near-normal lung circulation, but only if someone thinks to look for it.
Arterial Clots and the Race Against the Clock
Arterial thrombosis operates on a completely different timescale from venous clots. When an artery supplying the brain becomes blocked, the tissue downstream begins dying within minutes. Stroke is the second leading cause of death worldwide and a major cause of long-term disability, and the overwhelming majority of strokes are caused by arterial blockage. Treatment with clot-dissolving drugs or mechanical retrieval of the clot can reduce disability, but the window is narrow and the benefit drops sharply with every passing hour.9Nature Reviews Disease Primers. Ischaemic stroke An untreated arterial stroke can mean permanent loss of speech, movement, cognition, or life, depending on which brain region loses its blood supply.
Heart attacks follow a similar logic. When a coronary artery clot is not opened quickly, heart muscle dies and is replaced by scar tissue. The longer the artery stays blocked, the more muscle is lost, and the weaker the heart becomes permanently.
In the limbs, an arterial clot that cuts off blood flow to an arm or leg creates acute limb ischemia, and the timeline is brutally short. If a patient presents within six to eight hours and already has paralysis or numbness, limb loss is likely. Attempts to restore blood flow after ten to twelve hours of severe ischemia are often unsuccessful, and the patient faces either amputation or death from the toxic byproducts that flood the bloodstream when dying tissue is suddenly reperfused.10PubMed. Management of acute lower extremity arterial ischemia due to embolism and thrombosis When the limb is irreversibly damaged, amputation becomes the only option.11PubMed Central. One of the most urgent vascular circumstances: Acute limb ischemia
Small Clots That Dissolve Without Treatment
Not every blood clot is a crisis. Most deep vein thromboses actually start in the small veins of the calf, and most of those probably dissolve on their own without anyone ever knowing they were there. Clots that stay confined to the calf veins rarely cause leg symptoms or symptomatic pulmonary embolism. The risk increases substantially only when a calf clot extends upward into the larger veins of the thigh and pelvis.12PubMed. Natural history of venous thromboembolism
A study tracking the natural history of isolated calf vein clots found that they led to few early complications and few problems at the three-year mark. Most of the clots dissolved within three months. However, about 30% of patients developed valve damage in nearby veins, even veins that were not directly involved with the clot. Whether that valve damage leads to significant problems later on remains an open question.13PubMed. The natural history of calf vein thrombosis: lysis of thrombi and development of reflux This is one reason clinicians sometimes disagree about whether to treat small, isolated calf clots with blood thinners or simply monitor them with repeat imaging.
How Treatment Delays Shift the Odds
Even among patients who do eventually receive treatment, delays worsen outcomes. One study comparing early versus delayed treatment of DVT found that pulmonary embolism occurred in about a third of delayed-treatment patients compared to a fifth of those treated promptly. Death occurred in 9% of the delayed group versus 5% of those treated early.14PubMed Central. Delayed diagnosis and treatment of deep vein thrombosis – an underrecognized factor for its related outcomes? Residual clot material at follow-up was also more common when treatment came late.
Another study found that patients whose anticoagulation was delayed had higher rates of death and major bleeding at 90 days, though the increases in clot recurrence did not reach statistical significance.15PubMed Central. Delayed anticoagulation in venous thromboembolism: Reasons and associated outcomes The bleeding finding may seem counterintuitive since anticoagulants are supposed to cause bleeding, not prevent it, but the explanation likely involves the progression of disease during the untreated window, making the eventual treatment riskier. Recurrent clot events also carry their own morbidity and mortality above and beyond the initial episode.16PubMed Central. Assessing the risk of recurrent venous thromboembolism–a practical approach
Widespread Microvascular Clotting in Severe Infection
There is a less familiar but devastating form of untreated clotting that occurs throughout the body’s smallest vessels during severe sepsis. Disseminated intravascular coagulation, or DIC, involves tiny clots forming in capillaries and small vessels throughout multiple organs at once. As the clotting system goes into overdrive, it consumes the body’s supply of platelets and clotting proteins, which paradoxically leaves the patient at risk of uncontrolled bleeding at the same time that microclots are damaging organs.17PubMed. Sepsis, thrombosis and organ dysfunction
Post-mortem studies of patients who died from sepsis reveal microclots scattered across the kidneys, liver, lungs, gut, adrenal glands, and brain, with the degree of organ damage closely matching the density of clots.18PubMed. The role of microvascular thrombosis in sepsis When this process becomes generalized, it can trigger multi-organ failure and death.19PubMed Central. Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease DIC is not something a person could leave untreated by choice; it develops in patients already hospitalized for severe infection. But it illustrates the extreme end of what unchecked clotting can do to the body when there is no intervention to break the cycle.
Clots in Unusual Locations
Most discussions of untreated clots focus on the legs, lungs, heart, and brain arteries, but clots can form in less obvious places and create diagnostic puzzles when they go unrecognized. Cerebral venous sinus thrombosis, where clots block the veins that drain blood from the brain, is one example. It is uncommon enough that it is frequently missed on initial presentation. When the diagnosis is delayed or entirely missed, patients can develop chronic symptoms that mimic other neurological conditions, making correct diagnosis even harder over time.20PubMed Central. Missed Cerebral Venous Thrombosis: A Diagnostic Challenge The long-term presentations of untreated cerebral venous thrombosis remain poorly studied, partly because the condition is rare and partly because chronic cases present so variably that they may never get the right diagnosis.
Blood Clots During Pregnancy
Pregnancy shifts the blood’s clotting balance toward being more “pro-clot,” which makes biological sense for preventing hemorrhage during delivery but also increases the risk of thrombosis. When a woman has an underlying tendency toward clotting, called thrombophilia, pregnancy can tip the scales toward serious complications. Untreated thrombophilia during pregnancy has been linked not just to blood clots in the legs and lungs but also to severe preeclampsia, poor fetal growth, placental abruption, stillbirth, and recurrent miscarriage.21PubMed Central. Thrombophilia and pregnancy
The connection between clotting and these pregnancy complications is thought to involve microclots forming in the placental blood vessels, which starve the developing fetus of nutrients and oxygen. This is an area where treatment, typically low-dose blood thinners during pregnancy, can make a meaningful difference in outcomes. Women who have experienced recurrent pregnancy losses are now routinely screened for clotting disorders, which represents a significant shift from even a couple of decades ago.
When Children Develop Clots
Blood clots in children are uncommon compared to adults, with an estimated incidence of roughly 0.07 to 0.49 cases per 10,000 children per year. But when they do occur, they are overwhelmingly tied to medical interventions, particularly central venous catheters. Up to 90% of clotting events in hospitalized children are associated with these devices.22PubMed Central. Pediatric thrombosis: Risk factors, diagnosis, and prevention strategies The consequences of untreated clots in children follow the same general patterns as in adults: risk of embolism, risk of chronic vein damage, and in the case of arterial clots, risk of stroke or tissue death. But pediatric clots can be particularly insidious because they are not on most people’s radar. A swollen leg in a toddler with a central line may be attributed to the IV itself rather than to a clot forming around it.
Children also have the additional concern of growing into the consequences. Post-thrombotic syndrome in a child’s leg can affect limb growth and create a lifelong discrepancy in leg size or chronic skin problems. The stakes of catching and treating pediatric clots early are arguably higher than in an elderly patient, because the years of living with the downstream damage stretch much further ahead.